Allergan Aesthetics (AbbVie) CoolSculpting (Legacy/Gen 1-2)
Cryolipolysis · Cryolipolysis fat freezing
The Allergan Aesthetics (AbbVie) CoolSculpting (Legacy/Gen 1-2) typically sells new in the $100k–$150k range in the US, with used and refurbished systems around $15k–$45k. Allergan Aesthetics (AbbVie) CoolSculpting (Legacy/Gen 1-2) holds FDA 510(k) clearance for its marketed indication. Figures are market estimates verified August 9, 2026.
What it's actually cleared for: Family clearance: earlier CoolSculpting generations are covered by the Zeltiq/Allergan cryolipolysis (cold-assisted lipolysis) clearance lineage. Confirm the specific 510(k) for your serial number on accessdata.fda.gov.
Last verified: August 9, 2026 · How we verify
New: $100k–$150k|Used: $15k–$45kmarket estimate, no email required
| Manufacturer | Allergan Aesthetics (AbbVie) |
|---|---|
| Company | Owner: AbbVie Inc. (NYSE: ABBV) (subsidiary, since 2020) · Distribution: direct |
| Category | Body Contouring |
| Technology | Cryolipolysis fat freezing |
| FDA status | FDA Cleared |
| New price range | $100k–$150k |
| Used price range | $15k–$45k |
| Consumables | Not published |
| Launch year | 2010 |
| Last verified | August 9, 2026 |
Bottom line
A legacy CoolSculpting unit at $15k-45k looks like the deal of the decade against a $150k-250k Elite — until you understand the machine is a vending machine for Allergan cycle credits. Every treatment debits a prepaid cycle card the console reads; no cycles, no treatment — and Allergan has been sunsetting legacy support and card access to force Elite trade-ins. Buyers with a live Allergan account and a stash of cycles can mint money on residual consumer demand; buyers without confirmed card supply are purchasing a locked appliance. Price every deal off the included applicators and cycle inventory, and verify card availability with Allergan in writing before closing.
Overview
Original single-applicator system, huge used market
How it works
The science
Cryolipolysis: a vacuum applicator draws a fat bulge between cooling panels and holds it at precisely controlled cold (Gen-2 CoolAdvantage-era cycles ~35 minutes at lower temperatures vs the original 60), selectively triggering apoptosis in adipocytes — more cold-sensitive than skin, nerve, muscle. Macrophages clear the dead fat over 1-3 months for a measured 20-25% reduction in the treated bulge. Cleared areas grew to abdomen, flanks, thighs, submental, upper arms, bra/back fat, banana roll (BMI ≤30). Post-treatment massage measurably improves outcomes; results are permanent for treated cells but not weight-proof.
Patented tech
The Zeltiq cryolipolysis patent estate — licensed from the Mass General work of Anderson and Manstein — covering selective cold-induced adipocyte apoptosis, plus Freeze Detect skin-protection sensing and the vacuum applicator geometry; this moat is why "fat freezing" clones fought clearance battles for a decade.
Origin
Zeltiq Aesthetics, Pleasanton, California (Allergan/AbbVie after 2017).
FDA & regulatory status
What it's actually cleared for:
Family clearance: earlier CoolSculpting generations are covered by the Zeltiq/Allergan cryolipolysis (cold-assisted lipolysis) clearance lineage. Confirm the specific 510(k) for your serial number on accessdata.fda.gov.
De Novo / 510(k) numbers
DEN090002; K080521; K120023
Applicant on the FDA record
ZELTIQ Aesthetics, Inc.The applicant named on the FDA record can differ from the brand shown on the device.
Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.
Recent industry events
How we source company dataOwnership and corporate changes at Allergan Aesthetics (AbbVie) that can affect warranty, service and parts availability.
- May 2020
AbbVie completes acquisition of Allergan
AcquisitionAbbVie completed its acquisition of Allergan plc on May 8, 2020, making AbbVie the owner of Zeltiq and CoolSculpting. Allergan had itself acquired Zeltiq for ~$2.475B in April 2017. Largest ownership change touching the US aesthetic device market in this period.
Source: PR Newswire; SEC filings
Treatment economics
What practices charge
$600-800 per cycle with most patients needing 2-6 cycles — real tickets $1,500-4,000 per area-plan; submental $700-900. Legacy operators often discount 10-20% under Elite practices to keep volume.
Consumables & recurring cost
Three layers: cycle cards (the hard lockout — cycles historically ~$50-165 each from Allergan, with legacy-compatible cards now scarce and trading at premiums through resellers), single-use gel liners/gelpads (~$10-20/treatment), and applicator refurbishment as vacuum seals and sensors age. The cycle-card exposure is existential: model ROI on documented, transferable cycle access, and treat pre-loaded cycles as the real value in any sale.
Ideal for
Best-fit practice
A practice with an existing Allergan Aesthetics relationship, 15+ cycles/month of demand, and eyes open about a 3-5 year platform runway. Wrong buy for a first-time owner with no Allergan account — get written confirmation you can buy cycles before you shop consoles.
Compliance
Medical director & delegation
Class II prescription device operated widely by RNs and trained aestheticians under physician supervision depending on state — the delegation-friendly profile is why medspas built empires on it.
Contraindications & screening
Cryoglobulinemia, cold agglutinin disease, paroxysmal cold hemoglobinuria (absolute); hernia in the treatment zone, pregnancy, impaired sensation. Counsel every patient on paradoxical adipose hyperplasia — rare but litigated and highly publicized.
Ownership
Warranty & service
Allergan service for Gen 1-2 has effectively ended in favor of Elite trade-ins, leaving third-party techs handling chiller loops, umbilicals, and applicator sensors — parts are salvage-sourced and thinning. Any unit without recent applicator refurb records should be priced as needing $3k-8k of work.
Resale & used market
$15k-45k by applicator count and included cycles, on a clear downtrend as card access tightens; expect continued depreciation toward salvage value — buy for cash flow, not exit.
Chains using this device
SKINNEY Medspa
Medspa · 4 US locations · Company site
Confirmed
Owner reviews
Write a reviewNo verified reviews yet — be the first. Founding reviewers get a thank-you gift card for an honest review, positive or negative. How verification works.
Alternatives
Allergan Aesthetics (AbbVie) CoolSculpting Elite
Cryolipolysis · $150k–$250k with dual applicators
Head-to-head comparisons buyers ask for
History
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 9, 2026
FDA K-numbers
DEN090002; K080521; K120023
Source: Automatic record update
August 5, 2026
Warranty & service
Allergan service for Gen 1-2 has effectively ended in favor of Elite trade-ins, leaving third-party techs handling chiller loops, umbilicals, and applicator sensors — parts are salvage-sourced and thinning. Any unit without recent applicator refurb records should be priced as needing $3k-8k of work.
Source: Automatic record update
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Get the full State of Aesthetic Devices 2026 report
The first full census of the US aesthetic device market — preview it free.